ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Form 6-K — Oct 28, 2026
Ascentage Pharma announced that on October 27, 2026 its Trustee purchased 200,000 existing shares on the Hong Kong Stock Exchange for approximately HK$5.64 million (about HK$28.22 per share) to satisfy RSUs under the 2022 RSU Scheme. The purchase represents roughly 0.05% of issued shares, bringing cumulative trustee on-market purchases under the scheme to 3,315,000 shares.
Key figures
- Purchased Shares
- 200000
- Total Consideration
- HK$5,644,472
- Average Price Per Share
- approximately HK$28.22
- Percent Of Issued Shares
- approximately 0.05%
- Cumulative Trustee Purchases
- 3315000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.